Perindopril/Amlodipine (Prestalia®): A Review in Hypertension

@article{Shirley2015PerindoprilAmlodipineA,
  title={Perindopril/Amlodipine (Prestalia{\textregistered}): A Review in Hypertension},
  author={Matt Shirley and Paul L. McCormack},
  journal={American Journal of Cardiovascular Drugs},
  year={2015},
  volume={15},
  pages={363-370}
}
Perindopril, an ACE inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, are established antihypertensive agents with complementary mechanisms of action. [...] Key Result As demonstrated in short-term randomized controlled trials, perindopril/amlodipine FDC was significantly more effective in reducing blood pressure (BP) than monotherapy with either of the component drugs, and it appeared to be more effective than an up-titration scheme using valsartan and valsartan/amlodipine.Expand
Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice
TLDR
The perindopril/amlodipine FDC is characterized by high adherence and effectiveness, regardless of previous treatment, and was related to baseline BP levels. Expand
Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini review
TLDR
Current understanding of how genetic variants account for the observed variability in BP response in patients on first-line antihypertensive drugs, amlodipine and hydrochlorothiazide is described and enhanced. Expand
Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity
TLDR
Results indicate that clinical use of S-AML has an advantage not only because of greater pharmacological effect, but also because of fewer side effects and drug–drug interactions with cytochrome P450 substrates due to absence of R-AMl. Expand
Evaluation of pharmacokinetics and safety with bioequivalence of Amlodipine in healthy Chinese volunteers: Bioequivalence Study Findings
TLDR
The aim of this trial was to explore the pharmacokinetics and safety with bioequivalence of orally administered Amlodipine provided by two sponsors in healthy volunteers (HVs). Expand
F. A. KOVALENKO, V. V. SKIBITSKY, A. V. FENDRIKOVA, K. YU. LAZAREV, I. A. LUKONIN EFFICIENCY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY DEPENDING ON
  • 2018
Aim. To assess the efficiency of combined antihypertensive therapy in patients with arterial hypertension and obesity depending on the polymorphism of CYP2C9 gene. 95 Kuanskij nachnyj m edinskijExpand
VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY IN RURAL MALES WITH ARTERIAL HYPERTENSION: THE POSSIBILITIES OF MODIFYING IN REAL CLINICAL SETTINGS
TLDR
In rural HTN males, at 1yFU, the AHT (based on P/A, with IND addition as required) favored the significant blood pressure VVV reduction in the vast majority of cases. Expand
Supramolecular Synthon Approach in Developing Anti-Inflammatory Topical Gels for In Vivo Self-Delivery.
TLDR
A new series of tertiary-butyl ammonium (TBA) salts of various nonsteroidal anti-inflammatory drugs (NSAIDs) have been synthesized and characterized and a methyl salicylate topical gel derived from FLR was successfully delivered in a self-delivery fashion to treat inflamed skin conditions in the mice model. Expand
First and Highly Stereoselective Synthesis of Both Enantiomers of Octahydroindole‐2‐phosphonic Acid (OicP)
We report the first stereoselective synthesis of (2R,3aR,7aR)- and (2S,3aS,7aS)-octahydroindole-2-phosphonic acid 2 (OicP derivatives). The key points are the highly diastereoselective synthesis ofExpand
INTERRELATION OF ANTIHYPERTENSIVE EFFECT OF COMBINATION OF VALSARTAN AND AMLODIPINE WITH VARIOUS POLYMORPHIC VARIANTS OF GENES CYP2C9 AND CYP11B2 IN PATIENTS WITH OBESITY
TLDR
This document is intended to assist in the preparation of future studies on CyP2C9 and CYP11B2, as well as other similar studies, as needed. Expand
Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CYP11B2 genes
Purpose. To evaluate the efficiency of combination antihypertensive therapy with valsartan and amlodipine in patients with arterial hypertension (AH) and obesity, depending on the polymorphisms ofExpand

References

SHOWING 1-10 OF 39 REFERENCES
Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.
TLDR
Clinical experience confirms initial findings, perindopril is likely to represent a useful alternative to other members of the ACE inhibitor class in all grades of hypertension and congestive heart failure. Expand
Rationale for a single-pill combination of perindopril arginine and amlodipine besylate.
  • W. Elliott
  • Medicine
  • Journal of the American Society of Hypertension : JASH
  • 2015
TLDR
The single-pill combination of perindopril and amlodipine may be a useful addition to the antihypertensive armamentarium. Expand
Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.
TLDR
Amlodipine provides an attractive therapeutic option for the treatment of hypertension, and offers potential for patients with angina pectoris, and its beneficial effects in patients with congestive heart failure require confirmation in future studies. Expand
Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.
TLDR
Amlodipine seems to provide a useful alternative to other agents currently available for the treatment of essential hypertension and chronic stable angina pectoris, with certain pharmacodynamic and tolerability properties that should be advantageous in many patients. Expand
Perindopril. A review of its pharmacokinetics and clinical pharmacology.
TLDR
There is little published experience of the use of perindopril in patients with cardiac failure or other cardiac disease, but preliminary evidence would support the general value of this class of agent as adjunctive therapy. Expand
Efficacy and safety of perindopril arginine + amlodipine in hypertension.
TLDR
No deaths or significant differences across groups in early discontinuation, serum potassium, or rates of total or serious adverse events or glomerular filtration, were observed. Expand
Optimization of blood pressure treatment with fixed-combination perindopril/amlodipine in patients with arterial hypertension.
TLDR
Assessment of the blood pressure-lowering effects of fixed-combination perindopril/amlodipine in patients previously treated with an ACE inhibitor and/or a CCB found this treatment was well tolerated and resulted in clinically meaningful decreases in blood pressure. Expand
The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension
TLDR
The combination of OLM/AMl was superior to PER/AML in reducing CSBP and other efficacy measures, including a significantly higher rate of BP normalization. Expand
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri
TLDR
The amlodipine-based regimen prevented more major cardiovascular events and induced less diabetes than the atenolol- based regimen, and these effects might not be entirely explained by better control of blood pressure. Expand
Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study.
TLDR
Fixed combination perindopril/amlodipine was found to be an effective and well tolerated antihypertensive treatment, with an excellent rate of treatment adherence in the clinical setting. Expand
...
1
2
3
4
...